FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2102896380> ?p ?o ?g. }

• W2102896380 endingPage "746" @default.
• W2102896380 startingPage "741" @default.
• W2102896380 abstract "HomeCirculationVol. 72, No. 4Adenosine diphosphate as a mediator of platelet aggregation in vivo: an editorial view. Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBAdenosine diphosphate as a mediator of platelet aggregation in vivo: an editorial view. G V Born G V BornG V Born Search for more papers by this author Originally published1 Oct 1985https://doi.org/10.1161/01.CIR.72.4.741Circulation. 1985;72:741–746 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Effendi M, Smetana K and Berger K (2022) Other Antithrombotics: Antiplatelets and Fibrinolytics Transfusion Practice in Clinical Neurosciences, 10.1007/978-981-19-0954-2_33, (347-361), . Li F, Liang Y, Han X, Guan Y, Chen J, Wu P, Zhao X and Jing Q (2020) ADP receptor P2y12 prevents excessive primitive hematopoiesis in zebrafish by inhibiting Gata1, Acta Pharmacologica Sinica, 10.1038/s41401-020-0431-5, 42:3, (414-421), Online publication date: 1-Mar-2021. Li X, Liu P, Xu Z, Sun D, Gu J, Miao Y, Zhang J and Cao X (2020) A Pharmacodynamic Study of CN-218, a Novel Antiplatelet and Antithrombotic Agent Primarily Targeting the P2Y12 Receptor, Cardiovascular Drugs and Therapy, 10.1007/s10557-019-06930-9, 34:1, (15-23), Online publication date: 1-Feb-2020. Aslan J (2017) Platelet Shape Change Platelets in Thrombotic and Non-Thrombotic Disorders, 10.1007/978-3-319-47462-5_24, (321-336), . Aungraheeta R, Conibear A, Butler M, Kelly E, Nylander S, Mumford A and Mundell S (2016) Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor, Blood, 10.1182/blood-2016-03-707844, 128:23, (2717-2728), Online publication date: 8-Dec-2016. Sayre N, Chen Y, Sifuentes M, Stoveken B and Lechleiter J (2014) Purinergic Receptor Stimulation Decreases Ischemic Brain Damage by Energizing Astrocyte Mitochondria Glutamate and ATP at the Interface of Metabolism and Signaling in the Brain, 10.1007/978-3-319-08894-5_7, (121-150), . Hou X, Shi J and Sun H (2014) Gene polymorphism of cytochrome P450 2C19*2 and clopidogrel resistance reflected by platelet function assays: a meta-analysis, European Journal of Clinical Pharmacology, 10.1007/s00228-014-1714-x, 70:9, (1041-1047), Online publication date: 1-Sep-2014. Ferri N, Corsini A and Bellosta S (2013) Pharmacology of the New P2Y12 Receptor Inhibitors: Insights on Pharmacokinetic and Pharmacodynamic Properties, Drugs, 10.1007/s40265-013-0126-z, 73:15, (1681-1709), Online publication date: 1-Oct-2013. Jakubowski J, Zhou C, Small D, Winters K, Lachno D, Frelinger A, Howard J, Mant T, Jurcevic S and Payne C (2013) A phase 1 study of prasugrel in patients with sickle cell disease: pharmacokinetics and effects on ex vivo platelet reactivity , British Journal of Clinical Pharmacology, 10.1111/bcp.12042, 75:6, (1433-1444), Online publication date: 1-Jun-2013. Gachet C (2012) P2Y12 receptors in platelets and other hematopoietic and non-hematopoietic cells, Purinergic Signalling, 10.1007/s11302-012-9303-x, 8:3, (609-619), Online publication date: 1-Sep-2012. Hechler B and Gachet C (2011) P2 receptors and platelet function, Purinergic Signalling, 10.1007/s11302-011-9247-6, 7:3, (293-303), Online publication date: 1-Sep-2011. O’Connor S, Montalescot G and Collet J (2011) The P2Y12 receptor as a target of antithrombotic drugs, Purinergic Signalling, 10.1007/s11302-011-9241-z, 7:3, (325-332), Online publication date: 1-Sep-2011. Sur T (2011) Effects of Indian herbal formulation Body Revival on human platelet aggregation and myocardial ischemia in rats, Journal of Chinese Integrative Medicine, 10.3736/jcim20110708, 9:7, (746-751), Online publication date: 15-Jul-2011. Ueno M, Rao S and Angiolillo D (2010) Elinogrel: pharmacological principles, preclinical and early phase clinical testing, Future Cardiology, 10.2217/fca.10.67, 6:4, (445-453), Online publication date: 1-Jul-2010. Gachet C (2006) REGULATION OF PLATELET FUNCTIONS BY P2 RECEPTORS, Annual Review of Pharmacology and Toxicology, 10.1146/annurev.pharmtox.46.120604.141207, 46:1, (277-300), Online publication date: 1-Feb-2006. Gachet C, Léon C and Hechler B (2006) The platelet P2 receptors in arterial thrombosis, Blood Cells, Molecules, and Diseases, 10.1016/j.bcmd.2005.12.024, 36:2, (223-227), Online publication date: 1-Mar-2006. Shankar H, Kahner B, Prabhakar J, Lakhani P, Kim S and Kunapuli S (2006) G-protein–gated inwardly rectifying potassium channels regulate ADP-induced cPLA2 activity in platelets through Src family kinases, Blood, 10.1182/blood-2006-03-010330, 108:9, (3027-3034), Online publication date: 1-Nov-2006. Aras C, Baslar Z, Unal M and Horoz H (2018) Comparison of the Effect of Healon, Healon GV, Healon 5, Viscoat, and OcuCoat on Platelet Aggregation under in vitro Conditions , European Journal of Ophthalmology, 10.1177/112067210601600218, 16:2, (306-310), Online publication date: 1-Mar-2006. Lahiri P, Chaudhuri U, Chattopadhyay A, Chakraborty P, Mandal D and Dasgupta A (2005) Structural insights in platelet receptor synergism-antiplatelet therapy in post-ischemic cerebrovascular events, Blood Cells, Molecules, and Diseases, 10.1016/j.bcmd.2005.01.003, 34:3, (248-256), Online publication date: 1-May-2005. Gachet C (2005) The platelet P2 receptors as molecular targets for old and new antiplatelet drugs, Pharmacology & Therapeutics, 10.1016/j.pharmthera.2005.03.009, 108:2, (180-192), Online publication date: 1-Nov-2005. Xiao H, Kovics R, Jackson V and Remick D (2004) Effects of platelet inhibitors on propyl gallate-induced platelet aggregation, protein tyrosine phosphorylation, and platelet factor 3 activation, Blood Coagulation & Fibrinolysis, 10.1097/00001721-200404000-00001, 15:3, (199-206), Online publication date: 1-Apr-2004. Barragan P, Bouvier J, Roquebert P, Macaluso G, Commeau P, Comet B, Lafont A, Camoin L, Walter U and Eigenthaler M (2003) Resistance to thienopyridines: Clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation, Catheterization and Cardiovascular Interventions, 10.1002/ccd.10497, 59:3, (295-302), Online publication date: 1-Jul-2003. Krötz F, Sohn H, Gloe T, Zahler S, Riexinger T, Schiele T, Becker B, Theisen K, Klauss V and Pohl U (2002) NAD(P)H oxidase–dependent platelet superoxide anion release increases platelet recruitment, Blood, 10.1182/blood.V100.3.917, 100:3, (917-924), Online publication date: 1-Aug-2002. Matsagas M, Geroulakos G and Mikhailidis D (2002) The Role of Platelets in Peripheral Arterial Disease: Therapeutic Implications, Annals of Vascular Surgery, 10.1007/s10016-001-0159-8, 16:2, (246-258), Online publication date: 1-Mar-2002. Vogel H, Vogel W, Schölkens B, Sandow J, Müller G and Vogel W (2002) Activity on blood constituents1 Drug Discovery and Evaluation, 10.1007/3-540-29837-1_3, (277-309), . Kariyazono H, Nakamura K, Shinkawa T, Yamaguchi T, Sakata R and Yamada K (2001) Inhibition of Platelet Aggregation and the Release of P-Selectin from Platelets by Cilostazol, Thrombosis Research, 10.1016/S0049-3848(00)00415-1, 101:6, (445-453), Online publication date: 1-Mar-2001. Schwarz U, Kobsar A, Koksch M, Walter U and Eigenthaler M (2000) Inhibition of agonist-induced p42 and p38 mitogen-activated protein kinase phosphorylation and CD40 ligand/P-selectin expression by cyclic nucleotide-regulated pathways in human platelets, Biochemical Pharmacology, 10.1016/S0006-2952(00)00452-4, 60:9, (1399-1407), Online publication date: 1-Nov-2000. Geiger J (2005) Anti-aggregatory drugs: I. Platelet receptor antagonists, Expert Opinion on Therapeutic Patents, 10.1517/13543776.9.10.1389, 9:10, (1389-1414), Online publication date: 1-Oct-1999. Trumel C, Payrastre B, Plantavid M, Hechler B, Viala C, Presek P, Martinson E, Cazenave J, Chap H and Gachet C (1999) A Key Role of Adenosine Diphosphate in the Irreversible Platelet Aggregation Induced by the PAR1-Activating Peptide Through the Late Activation of Phosphoinositide 3-Kinase, Blood, 10.1182/blood.V94.12.4156.424k29_4156_4165, 94:12, (4156-4165), Online publication date: 15-Dec-1999. Trumel C, Payrastre B, Plantavid M, Hechler B, Viala C, Presek P, Martinson E, Cazenave J, Chap H and Gachet C (1999) A Key Role of Adenosine Diphosphate in the Irreversible Platelet Aggregation Induced by the PAR1-Activating Peptide Through the Late Activation of Phosphoinositide 3-Kinase, Blood, 10.1182/blood.V94.12.4156, 94:12, (4156-4165), Online publication date: 15-Dec-1999. Andrews D and Low P (1999) Role of red blood cells in thrombosis, Current Opinion in Hematology, 10.1097/00062752-199903000-00004, 6:2, (76), Online publication date: 1-Mar-1999. Schrör K (2016) Clinical pharmacology of the adenosine diphosphate (ADP) receptor antagonist, clopidogrel, Vascular Medicine, 10.1177/1358836X9800300312, 3:3, (247-251), Online publication date: 1-Aug-1998. Geiger J, Hönig-Liedl P, Schanzenbächer P and Walter U (1998) Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors, European Journal of Pharmacology, 10.1016/S0014-2999(98)00305-7, 351:2, (235-246), Online publication date: 1-Jun-1998. Vogel H and Vogel W (1997) Activity on blood constituents Drug Discovery and Evaluation, 10.1007/978-3-662-03333-3_2, (150-167), . Gachet C, Payrastre B, Guinebault C, Trumel C, Ohlmann P, Mauco G, Cazenave J, Plantavid M and Chap H (1997) Reversible Translocation of Phosphoinositide 3-Kinase to the Cytoskeleton of ADP-aggregated Human Platelets Occurs Independently of Rho A and without Synthesis of Phosphatidylinositol (3,4)-Bisphosphate, Journal of Biological Chemistry, 10.1074/jbc.272.8.4850, 272:8, (4850-4854), Online publication date: 1-Feb-1997. Gachet C and Cazenave J (1997) Platelet ADP/Purinergic Receptors Platelets and Their Factors, 10.1007/978-3-642-60639-7_6, (117-134), . Born G and Collins R (1997) Aspirin versus clopidogrel: the wrong question?, The Lancet, 10.1016/S0140-6736(05)60237-1, 349:9054, (806-807), Online publication date: 1-Mar-1997. Savi P and Herbert J (1998) ADP receptors on platelets and ADP‐selective antiaggregating agents, Medicinal Research Reviews, 10.1002/(SICI)1098-1128(199603)16:2<159::AID-MED2>3.0.CO;2-#, 16:2, (159-179), Online publication date: 1-Mar-1996. Gachet C, Hechler B, Léon C, Vial C, Ohlmann P and Cazenave J (2009) Purinergic receptors on blood platelets, Platelets, 10.3109/09537109609023587, 7:5-6, (261-267), Online publication date: 1-Jan-1996. Schmid-Schönbein H and Perktold K (1995) Physical Factors in the Pathogenesis of Atheroma Formation Brain Ischemia, 10.1007/978-1-4471-2073-5_20, (185-213), . Gachet C, Cattaneo M, Ohlmann P, Hechler B, Lecchi A, Chevalier J, Cassel D, Mannucci P and Cazenave J (1995) Purinoceptors on blood platelets: further pharmacological and clinical evidence to suggest the presence of two ADP receptors, British Journal of Haematology, 10.1111/j.1365-2141.1995.tb05319.x, 91:2, (434-444), Online publication date: 1-Oct-1995. Gardell S (1994) Ticlopidine and clopidogrel: Antithrombotic agents that block ADP-mediated platelet activation, Perspectives in Drug Discovery and Design, 10.1007/BF02171863, 1:3, (521-526), Online publication date: 1-Apr-1994. Herbert J, Bernat A and Maffrand J (1993) Aprotinin reduces clopidogrel-induced prolongation of the bleeding time in the rat, Thrombosis Research, 10.1016/0049-3848(93)90117-7, 71:6, (433-441), Online publication date: 1-Sep-1993. Schrör K (2009) The Basic Pharmacology of Ticlopidine and Clopidogrel, Platelets, 10.3109/09537109309013225, 4:5, (252-261), Online publication date: 1-Jan-1993. Herbert J, Frehel D, Vallee E, Kieffer G, Gouy D, Berger Y, Necciari J, Defreyn G and Maffrand J (1993) Clopidogrel, A Novel Antiplatelet and Antithrombotic Agent, Cardiovascular Drug Reviews, 10.1111/j.1527-3466.1993.tb00275.x, 11:2, (180-198), Online publication date: 1-Jun-1993. Lösche W, Vickers J, May J and Heptinstall S (1991) The platelet aggregating activity of 2,3-diphosphoglycerate may be caused by ADP impurity, Thrombosis Research, 10.1016/0049-3848(91)90246-S, 61:2, (175-177), Online publication date: 1-Jan-1991. Hendra T and Yudkin J (2009) Whole Blood Platelet Aggregation Based on Cell Counting Procedures, Platelets, 10.3109/09537109009005464, 1:2, (57-66), Online publication date: 1-Jan-1990. Dragan Y and Ellis E (1990) Effect of adenine nucleotides on cyclooxygenase and lipoxygenase enzyme products of arachidonic acid in human platelets, Biochemical Pharmacology, 10.1016/0006-2952(90)90644-Z, 39:1, (27-32), Online publication date: 1-Jan-1990. Hamm C, Terres W and Bleifeld W (1990) Platelet Activation in Patients with Unstable Angina Unstable Angina, 10.1007/978-3-642-61288-6_5, (81-91), . Leytin V, Misseiwitz F, Lyubimova E and Domogatsky S (1989) The role of platelet prostanoids and dense granule compounds in initial attachment. Spreading and aggregation of platelets on collagen substrates, Thrombosis Research, 10.1016/0049-3848(89)90048-0, 55:4, (395-406), Online publication date: 1-Aug-1989. L�thje J (1989) Extracellular adenine compounds, red blood cells and haemostasis: facts and hypotheses, Blut, 10.1007/BF00321207, 59:4, (367-374), Online publication date: 1-Oct-1989. Hendra T, Oughton J, Smith O, Betteridge D and Yudkin J (1988) Exercise-induced changes in platelet aggregation; a comparison of whole blood and platelet rich plasma techniques, Thrombosis Research, 10.1016/0049-3848(88)90028-X, 52:5, (443-451), Online publication date: 1-Dec-1988. Bassenge E and Busse R (1988) Endothelial modulation of coronary tone, Progress in Cardiovascular Diseases, 10.1016/0033-0620(88)90003-5, 30:5, (349-380), Online publication date: 1-Mar-1988. Helenski C and Ross J (1987) Platelet Aggregation in Feline Cardiomyopathy, Journal of Veterinary Internal Medicine, 10.1111/j.1939-1676.1987.tb01982.x, 1:1, (24-28), Online publication date: 1-Jan-1987. Haghighi F, Yesylevskyy S, Davani S and Ramseyer C (2021) Membrane Environment Modulates Ligand-Binding Propensity of P2Y12 Receptor, Pharmaceutics, 10.3390/pharmaceutics13040524, 13:4, (524) October 1, 1985Vol 72, Issue 4 Advertisement Article InformationMetrics Copyright © 1985 by American Heart Associationhttps://doi.org/10.1161/01.CIR.72.4.741 Originally publishedOctober 1, 1985 PDF download Advertisement" @default.
• W2102896380 created "2016-06-24" @default.
• W2102896380 creator A5000997568 @default.
• W2102896380 date "1985-10-01" @default.
• W2102896380 modified "2023-10-16" @default.
• W2102896380 title "Adenosine diphosphate as a mediator of platelet aggregation in vivo: an editorial view." @default.
• W2102896380 cites W1963667363 @default.
• W2102896380 cites W1966368873 @default.
• W2102896380 cites W1967511337 @default.
• W2102896380 cites W1967564284 @default.
• W2102896380 cites W1970482731 @default.
• W2102896380 cites W1973694893 @default.
• W2102896380 cites W1979692719 @default.
• W2102896380 cites W1983530856 @default.
• W2102896380 cites W1988302614 @default.
• W2102896380 cites W2008862271 @default.
• W2102896380 cites W2012214760 @default.
• W2102896380 cites W2023194722 @default.
• W2102896380 cites W2023935024 @default.
• W2102896380 cites W2029133236 @default.
• W2102896380 cites W2035423234 @default.
• W2102896380 cites W2049608295 @default.
• W2102896380 cites W2058470564 @default.
• W2102896380 cites W2059455520 @default.
• W2102896380 cites W2068706137 @default.
• W2102896380 cites W2088192665 @default.
• W2102896380 cites W2088371504 @default.
• W2102896380 cites W2095160367 @default.
• W2102896380 cites W2130503561 @default.
• W2102896380 cites W2135656227 @default.
• W2102896380 cites W2142010327 @default.
• W2102896380 cites W2406785414 @default.
• W2102896380 cites W2409444847 @default.
• W2102896380 cites W2411245105 @default.
• W2102896380 cites W2415863165 @default.
• W2102896380 cites W2884952479 @default.
• W2102896380 cites W91766283 @default.
• W2102896380 cites W412688833 @default.
• W2102896380 doi "https://doi.org/10.1161/01.cir.72.4.741" @default.
• W2102896380 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/4028375" @default.
• W2102896380 hasPublicationYear "1985" @default.
• W2102896380 type Work @default.
• W2102896380 sameAs 2102896380 @default.
• W2102896380 citedByCount "72" @default.
• W2102896380 countsByYear W21028963802012 @default.
• W2102896380 countsByYear W21028963802013 @default.
• W2102896380 countsByYear W21028963802014 @default.
• W2102896380 countsByYear W21028963802015 @default.
• W2102896380 countsByYear W21028963802016 @default.
• W2102896380 countsByYear W21028963802017 @default.
• W2102896380 countsByYear W21028963802020 @default.
• W2102896380 countsByYear W21028963802021 @default.
• W2102896380 countsByYear W21028963802022 @default.
• W2102896380 crossrefType "journal-article" @default.
• W2102896380 hasAuthorship W2102896380A5000997568 @default.
• W2102896380 hasBestOaLocation W21028963801 @default.
• W2102896380 hasConcept C126322002 @default.
• W2102896380 hasConcept C207001950 @default.
• W2102896380 hasConcept C2107291 @default.
• W2102896380 hasConcept C2776991684 @default.
• W2102896380 hasConcept C2777399203 @default.
• W2102896380 hasConcept C2993802102 @default.
• W2102896380 hasConcept C54355233 @default.
• W2102896380 hasConcept C71924100 @default.
• W2102896380 hasConcept C86803240 @default.
• W2102896380 hasConcept C89560881 @default.
• W2102896380 hasConcept C98274493 @default.
• W2102896380 hasConceptScore W2102896380C126322002 @default.
• W2102896380 hasConceptScore W2102896380C207001950 @default.
• W2102896380 hasConceptScore W2102896380C2107291 @default.
• W2102896380 hasConceptScore W2102896380C2776991684 @default.
• W2102896380 hasConceptScore W2102896380C2777399203 @default.
• W2102896380 hasConceptScore W2102896380C2993802102 @default.
• W2102896380 hasConceptScore W2102896380C54355233 @default.
• W2102896380 hasConceptScore W2102896380C71924100 @default.
• W2102896380 hasConceptScore W2102896380C86803240 @default.
• W2102896380 hasConceptScore W2102896380C89560881 @default.
• W2102896380 hasConceptScore W2102896380C98274493 @default.
• W2102896380 hasIssue "4" @default.
• W2102896380 hasLocation W21028963801 @default.
• W2102896380 hasLocation W21028963802 @default.
• W2102896380 hasOpenAccess W2102896380 @default.
• W2102896380 hasPrimaryLocation W21028963801 @default.
• W2102896380 hasRelatedWork W1998683556 @default.
• W2102896380 hasRelatedWork W2001512029 @default.
• W2102896380 hasRelatedWork W2015499118 @default.
• W2102896380 hasRelatedWork W2300575617 @default.
• W2102896380 hasRelatedWork W2358774113 @default.
• W2102896380 hasRelatedWork W2388710013 @default.
• W2102896380 hasRelatedWork W2404071001 @default.
• W2102896380 hasRelatedWork W2414263361 @default.
• W2102896380 hasRelatedWork W4241803129 @default.
• W2102896380 hasRelatedWork W4252771541 @default.
• W2102896380 hasVolume "72" @default.
• W2102896380 isParatext "false" @default.
• W2102896380 isRetracted "false" @default.
• W2102896380 magId "2102896380" @default.
• W2102896380 workType "article" @default.